These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3546074)

  • 1. Eicosanoid biosynthesis in human cardiovascular disease.
    Fitzgerald GA; Catella F; Oates JA
    Hum Pathol; 1987 Mar; 18(3):248-52. PubMed ID: 3546074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA; Doran JB; Smith B; FitzGerald GA
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical pharmacology of thromboxane synthase inhibition in man.
    FitzGerald GA; Reilly IA; Pedersen AK
    Circulation; 1985 Dec; 72(6):1194-201. PubMed ID: 3905048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2 biosynthesis in human disease.
    FitzGerald GA; Healy C; Daugherty J
    Fed Proc; 1987 Jan; 46(1):154-8. PubMed ID: 3100340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin and thromboxane in gynecology and obstetrics.
    Ylikorkala O; Mäkilä UM
    Am J Obstet Gynecol; 1985 Jun; 152(3):318-29. PubMed ID: 3890549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
    Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE
    N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
    FitzGerald GA; Lupinetti M; Charman SA; Charman WN
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
    Knapp HR; Reilly IA; Alessandrini P; FitzGerald GA
    N Engl J Med; 1986 Apr; 314(15):937-42. PubMed ID: 3007982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
    Adatia I; Barrow SE; Stratton P; Ritter JM; Haworth SG
    Br Heart J; 1993 Feb; 69(2):179-82. PubMed ID: 8435245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA; Eichler HG; Jäger U; Lechner K
    Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin and thromboxane A2 production by human cardiac atrial tissues.
    Mehta J; Mehta P
    Am Heart J; 1985 Jan; 109(1):1-3. PubMed ID: 3880988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
    Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.